These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 28783617

  • 1. An age dependent response to hydroxyurea in pediatric sickle cell anemia patients with alpha thalassemia trait.
    Figueiredo L, Morrone K, Wei C, Ireland K, Cohen HW, Driscoll C, Manwani D.
    Blood Cells Mol Dis; 2017 Jul; 66():19-23. PubMed ID: 28783617
    [Abstract] [Full Text] [Related]

  • 2. Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and α-thalassemia.
    Ballas SK, Connes P, Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Eur J Haematol; 2018 Dec; 101(6):798-803. PubMed ID: 30204261
    [Abstract] [Full Text] [Related]

  • 3. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.
    Darbari DS, Nouraie M, Taylor JG, Brugnara C, Castro O, Ballas SK.
    Eur J Haematol; 2014 Apr; 92(4):341-5. PubMed ID: 24330217
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia.
    Yahouédéhou SCMA, da Guarda CC, Figueiredo CVB, Santiago RP, Carvalho SP, Fiuza LM, Ndidi US, Oliveira RM, Carvalho MOS, Nascimento VML, Rocha LC, Lyra IM, Adorno EV, Goncalves MS.
    PLoS One; 2019 Apr; 14(7):e0218040. PubMed ID: 31306416
    [Abstract] [Full Text] [Related]

  • 7. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease.
    Rogers ZR.
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):42-7. PubMed ID: 9317200
    [Abstract] [Full Text] [Related]

  • 8. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
    Gueye Tall F, Martin C, Ndour EHM, Renoux C, Ly ID, Connes P, Gueye PM, Diallo RN, Diagne I, Diop PA, Cissé A, Lopez Sall P, Joly P.
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
    [Abstract] [Full Text] [Related]

  • 9. Hydroxyurea therapy in children severely affected with sickle cell disease.
    Scott JP, Hillery CA, Brown ER, Misiewicz V, Labotka RJ.
    J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
    [Abstract] [Full Text] [Related]

  • 10. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
    Tavakkoli F, Nahavandi M, Wyche MQ, Perlin E.
    Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
    [Abstract] [Full Text] [Related]

  • 11. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
    Sheehan VA, Luo Z, Flanagan JM, Howard TA, Thompson BW, Wang WC, Kutlar A, Ware RE, BABY HUG Investigators.
    Am J Hematol; 2013 Jul; 88(7):571-6. PubMed ID: 23606168
    [Abstract] [Full Text] [Related]

  • 12. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009 Jul; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 13. Growth Hormone/Insulin-like Growth Factor 1 Axis Associated with Modifier Factors in Children with Sickle Cell Anemia.
    Costa-Júnior DAD, Santos APP, da Silva CM, Velloso-Rodrigues C.
    Endocr Metab Immune Disord Drug Targets; 2022 Jul; 22(9):954-962. PubMed ID: 35240969
    [Abstract] [Full Text] [Related]

  • 14. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.
    Estepp JH, Smeltzer MP, Kang G, Li C, Wang WC, Abrams C, Aygun B, Ware RE, Nottage K, Hankins JS.
    Am J Hematol; 2017 Dec; 92(12):1333-1339. PubMed ID: 28913922
    [Abstract] [Full Text] [Related]

  • 15. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1993 Jan 14; 328(2):73-80. PubMed ID: 7677965
    [Abstract] [Full Text] [Related]

  • 16. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N, Fattori A, Saad ST, Costa FF.
    Am J Hematol; 2004 Aug 14; 76(4):343-7. PubMed ID: 15282666
    [Abstract] [Full Text] [Related]

  • 17. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
    Koc A, Gumruk F, Gurgey A.
    Pediatr Hematol Oncol; 2003 Sep 14; 20(6):429-34. PubMed ID: 14631615
    [Abstract] [Full Text] [Related]

  • 18. Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait.
    Adekile AD, Gupta R, Yacoub F, Sinan T, Al-Bloushi M, Haider MZ.
    Acta Haematol; 2001 Sep 14; 105(1):27-31. PubMed ID: 11340250
    [Abstract] [Full Text] [Related]

  • 19. Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort.
    Hatzlhofer BLD, Pereira-Martins DA, de Farias Domingos I, Arcanjo GDS, Weinhäuser I, Falcão DA, Farias ICC, de Freitas Batista JVG, Prado LPL, Oliveira JMF, Batista THC, Sobreira MJVC, de Santana RM, Araújo ABS, de Melo MA, de Ancântara BV, Coelho-Silva JL, de Moura Rafael ABL, de Lima Silva DM, Albuquerque FP, Santos MNN, Dos Anjos AC, Costa FF, da Silva Araújo A, Lucena-Araújo AR, Bezerra MAC.
    Ann Hematol; 2021 Apr 14; 100(4):921-931. PubMed ID: 33586016
    [Abstract] [Full Text] [Related]

  • 20. The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival.
    Rumaney MB, Ngo Bitoungui VJ, Vorster AA, Ramesar R, Kengne AP, Ngogang J, Wonkam A.
    PLoS One; 2014 Apr 14; 9(6):e100516. PubMed ID: 24978191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.